|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0009429,
umls-concept:C0022341,
umls-concept:C0123931,
umls-concept:C0205179,
umls-concept:C0282460,
umls-concept:C0556895,
umls-concept:C0879262,
umls-concept:C1515417,
umls-concept:C1518578,
umls-concept:C1705493
|
|
pubmed:issue |
16
|
|
pubmed:dateCreated |
2008-8-13
|
|
pubmed:abstractText |
To evaluate the efficacy and toxicity of combination therapy with the oral fluoropyrimidine formulation S-1 and irinotecan for patients with advanced NSCLC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:EbiNoriyukiN,
pubmed-author:FukuokaMasahiroM,
pubmed-author:KatakamiNobuyukiN,
pubmed-author:KuboAkihitoA,
pubmed-author:MiyazakiMasakiM,
pubmed-author:NakagawaKazuhikoK,
pubmed-author:NishimuraTakashiT,
pubmed-author:OkamotoIsamuI,
pubmed-author:SugawaraShunichiS,
pubmed-author:TakedaKojiK,
pubmed-author:YoshiokaHiroshigeH
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
5250-4
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18698044-Adult,
pubmed-meshheading:18698044-Aged,
pubmed-meshheading:18698044-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:18698044-Camptothecin,
pubmed-meshheading:18698044-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:18698044-Disease-Free Survival,
pubmed-meshheading:18698044-Drug Combinations,
pubmed-meshheading:18698044-Female,
pubmed-meshheading:18698044-Humans,
pubmed-meshheading:18698044-Japan,
pubmed-meshheading:18698044-Kaplan-Meier Estimate,
pubmed-meshheading:18698044-Lung Neoplasms,
pubmed-meshheading:18698044-Male,
pubmed-meshheading:18698044-Middle Aged,
pubmed-meshheading:18698044-Oxonic Acid,
pubmed-meshheading:18698044-Tegafur,
pubmed-meshheading:18698044-Treatment Outcome
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Phase II study of combination therapy with S-1 and irinotecan for advanced non-small cell lung cancer: west Japan thoracic oncology group 3505.
|
|
pubmed:affiliation |
Department of Medical Oncology, Kinki University School of Medicine, Osaka, Japan. chi-okamoto@dotd.med.kindai.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Multicenter Study,
Clinical Trial, Phase II
|
